XTL BIOPHARMACEUTICALS LTD. Sales And Marketing Expense
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Sales And Marketing Expense of $487.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2025-04-30
| Period end | Sales And Marketing Expense 12 month |
|---|---|
| 2024-12-31 | $487.00K 20-F · filed 2025-04-30 |